We are delighted and honored to introduce you to the Single topic Conference on HCV (Real Life Experience) of the Asian Pacific Association for the Study of the Liver (APASL) which will be held at Royal Maxim Palace Kempinski hotel , on 6-8 September 2017 in Cairo, Egypt. We will bring together a distinguished faculty of renowned specialists from AsiaPacific and around the world to this conference.
After the two successful liver fibrosis STC meetings in Cairo on 2008 and 2014, the coming congress have been selected to focus on HCV and its remarkable fast progress in the new treatment modalities. Egyptians have the highest world prevalence of HCV of 14.7%. Luckily, we have the first world national program treating all our patients. It will be a good opportunity to discuss with the world experts in this field the results of their researches, and the real life results of different national protocols that are currently ongoing specially in the AsiaPacific region. By reaching the date of the congress on September 2017, there will be more than one million Egyptian patients that have been cured from the virus using the currently available DAAs. The congress will provide an excellent opportunity to share and exchange experiences especially from the view of Asian Pacific countries regarding the latest scientific and evidence-based research results and recommendations to follow-up the cured patients, to treat their damaged liver cells, to dissolve their fibrous bands, to detect and treat early any rising liver cancers. These elements are essential to pave a way for better treatment of HCV patients not only in the AsiaPacific region but around the world.
In addition to the scientific program, an interesting social program for the doctors and their companions have been well prepared.
Waiting to welcome you in Cairo, on September 6-8, 2017
Best of our Greetings
Ever since its inception, in August 1978 in Singapore, APASL (Asian Pacific Association for the Study of the Liver) never looks back but stick to its goal towards advancing the science and practice of Hepatology.
Today it is one of the leading associations based on investigation and treatment of liver diseases in the world and the largest scientific body that upholds the standards and profession, research and create improved treatment methods for millions of liver patients particularly in the .entire Asia Pacific Region
The STC Conference of the Asian Pacific Association for the Study of the Liver' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.
was granted 15 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).
The EACCME is an institution of the European Union of Medical .Specialists (UEMS), www.uems.net Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found .at www.ama-assn.org/go/internationalcme
(Till 15 June)
(16 Jun - 05 Sep.)
|APASL Member||300 USD||350 USD||400 USD|
|Non-APASL Member||350 USD||400 USD||450 USD|
Royal Maxim Palace Kempinski
First Settlement, Eastern Ring Road,
Cairo, Cairo Governorate
+20 2 23899000